Know Cancer

or
forgot password
  • cancer clinical trials in virginia

  • Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Danville Regional Medical Center

    Trial Locations
    Danville Regional Medical Center
    Fredericksburg Oncology Inc
    Lynchburg Hematology-Oncology Clinic
    Memorial Hospital Of Martinsville
    Virginia Commonwealth University
    Hunter Holmes McGuire Veterans Administration Medical Center
    Community Memorial Health Center
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Pharmacogenetics of Metformin Action in PCOS
    University Of Virginia General Clinical Research Center

    Trial Locations
    University Of Virginia General Clinical Research Center
    Virginia Commonwealth University
    Polycystic Ovary Syndrome
    Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Thyroid Cancer
    Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
    Massey Cancer Center/Virginia Commonwealth University
    Richmond, Virginia 23298
    Non-Hodgkin's Lymphoma, Leukemia, Multiple Myeloma, Acute Myeloid Leukemia, Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome
    Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC
    GSK Investigational Site
    Salem, Virginia 24153
    Neoplasms, Breast
    To Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
    Urology of Virginia, Sentara Medical Group
    Norfolk, Virginia 23503
    Prostate Cancer
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    Children's Hospital of the King's Daughters

    Trial Locations
    Children's Hospital of the King's Daughters
    Virginia Commonwealth University Massey Cancer Center
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Carilion Gynecologic Oncology Associates
    Roanoke, Virginia 24014
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    Fredericksburg Oncology, Incorporated
    Fredericksburg, Virginia 22401
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Childrens Hospital-King's Daughters
    Norfolk, Virginia 23507
    Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma
    GSK Investigational Site
    Salem, Virginia 24153
    Carcinoma, Renal Cell
    5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodysplastic Syndrome
    Massey Cancer Center / Virginia Commonwealth University
    Richmond, Virginia 23298
    Myelodysplastic Syndrome
    Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Carilion Clinic Gynecological Oncology
    Roanoke, Virginia 24016
    Recurrent Endometrial Carcinoma
    BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma
    1200.36.0011 Boehringer Ingelheim Investigational Site
    Charlotteville, Virginia
    Glioma
    Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
    University of Virginia

    Trial Locations
    University of Virginia
    Carilion Clinic Gynecological Oncology
    Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    Inova Fairfax Hospital

    Trial Locations
    Inova Fairfax Hospital
    Virginia Commonwealth University
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Danville Regional Medical Center

    Trial Locations
    Danville Regional Medical Center
    Fredericksburg Oncology Inc
    Memorial Hospital Of Martinsville
    Virginia Commonwealth University
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Airway Epithelium Gene Expression: AEGIS II
    Virginia Commonwealth University
    Richmond, Virginia
    Lung Cancer
    Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
    Sentara Cancer Institute at Sentara Norfolk General Hospital
    Norfolk, Virginia 23507
    Lung Cancer
    Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor
    Virginia Center Specialists, Pc

    Trial Locations
    Virginia Center Specialists, Pc
    Virginia Oncology Associates
    Oncology & Hematology Associates of Southwest Virginia, Inc.
    Advanced Breast Cancer
    A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Norfolk, Virginia 23502
    Non-small Cell Lung Cancer
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    Oncology and Hematology Associates of Southwest Virginia, Inc.
    Roanoke, Virginia 24014
    Melanoma
    S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
    Danville Regional Medical Center

    Trial Locations
    Danville Regional Medical Center
    Southwest Virginia Regional Cancer Center at Wellmonth Health
    Malignant Mesothelioma
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    Virginia Commonwealth University
    Richmond, Virginia
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome
    Eastern Virginia Medical School
    Norfolk, Virginia 23507
    Carcinoid Syndrome
    Provenge (TM) for the Treatment of Hormone Sensitive Prostate Cancer
    Urology of Virginia, PC
    Norfolk, Virginia 23507
    Prostate Cancer
    Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
    Virginia Commonwealth University SC
    Richmond, Virginia 23284
    Leukemia
    Islet After Kidney Transplant for Type 1 Diabetes
    Virginia Commonwealth University Health System
    Richmond, Virginia 23298
    Type 1 Diabetes Mellitus
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Martha Jefferson Hospital

    Trial Locations
    Martha Jefferson Hospital
    University of Virginia
    Danville Regional Medical Center
    Medical Oncology Hematology Associates of Northern Virginia Limited
    Fredericksburg Oncology Inc
    Hematology Oncology Associates of Fredericksburg Inc
    Virginia Oncology Associates-Hampton
    Lynchburg Hematology-Oncology Clinic
    Memorial Hospital Of Martinsville
    Virginia Commonwealth University
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer